首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 1-乙基-6-氟-7-(4-甲基哌嗪-1-基)-4-氧代-1,4-二氢喹啉-3-羧酸甲磺酸盐

1-乙基-6-氟-7-(4-甲基哌嗪-1-基)-4-氧代-1,4-二氢喹啉-3-羧酸甲磺酸盐

1-Ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monomethanesulfonate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1g 98% 询价
- +
5g 98% 询价
- +
10g 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

70458-95-6

中文名称

1-乙基-6-氟-7-(4-甲基哌嗪-1-基)-4-氧代-1,4-二氢喹啉-3-羧酸甲磺酸盐

英文名称

1-Ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monomethanesulfonate

别名

1589 mR.B. | STL445507 | (3-hydroxypropyl)carbamic acid tert-butyl ester | 1-Ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid methanesulfonate (1:1); 1-Ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-qui

标准英文名

1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid--methanesulfonic acid (1/1)

分子式

C18H24FN3O6S

分子量

429.47

精确分子量

429.14

SMILES

O=C(C1=CN(CC)C2=C(C=C(F)C(N3CCN(C)CC3)=C2)C1=O)O.CS(=O)(O)=O

标准SMILES

CN1CCN(CC1)C1=CC2=C(C=C1F)C(=O)C(=CN2CC)C(O)=O.CS(O)(=O)=O

用途

Pefloxacin mesylate is a fluoroquinolone antibacterial agent used for the treatment of various infections caused by susceptible bacteria, including: urinary tract infections; respiratory tract infections; ear, nose, and throat infections; gynecological and reproductive system infections; intra-abdominal and hepatobiliary infections; bone and joint infections; skin infections; sepsis and endocarditis; and meningitis. It is particularly effective in severe infections involving the central nervous system, cardiovascular system, respiratory system, gynecological system, and bones. Due to its broad-spectrum activity and potent bactericidal effect—achieved by inhibiting bacterial DNA gyrase—it demonstrates efficacy comparable to or greater than third- and fourth-generation cephalosporins, newer aminoglycosides, and ciprofloxacin. It is also active against multidrug-resistant strains, including methicillin-resistant Staphylococcus aureus (MRSA), and shows no cross-resistance with other antibiotic classes. However, due to the risk of serious adverse reactions associated with fluoroquinolones, its use (especially the injectable form) should be reserved for cases where alternative treatments are not suitable, particularly for self-limiting conditions such as acute bacterial sinusitis, acute exacerbations of chronic bronchitis, uncomplicated urinary tract infections, and acute uncomplicated cystitis.

InChIKey

HQQSBEDKMRHYME-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  70458-95-6 逆合成路线 1

ACRDEA276
68077-26-9
现货
ACJACD865
34352-59-5
ACYQRH695
70458-95-6
来源: SureRoute

2.  70458-95-6 逆合成路线 2

—
—
ACBWGH045
70458-96-7
ACYQRH695
70458-95-6
来源: SureRoute

3.  70458-95-6 逆合成路线 3

—
—
ACYQRH695
70458-95-6
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手